Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Don't have an account? Register Here
<h1>Circular Clarifies DEPB Scheme: Bulk Drug DEPB Rates Exclude Formulations Unless Stated; Specific Entry for 75% Rate Application.</h1> The circular addresses the export of bulk drug formulations under the DEPB Scheme, clarifying that DEPB rates intended for bulk drugs should not be applied to their formulations unless explicitly stated. The DEPB Committee decided that formulations such as tablets, syrups, or injections are covered only under a specific entry (S.No.37) in the DEPB Rate Schedule, eligible for 75% of the DEPB rate for the relevant bulk drug. For example, Enalapril Maleate tablets are covered under one entry, while Erythromycin BP 88 formulations are not and should be listed under S.No.37 for the reduced rate. This decision is to be uniformly applied by customs officers and staff.